Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
2,74 USD | -2,49% | +3,79% | +18,61% |
Attività
Numero di dipendenti: 33
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Rare Disease Therapies
100,0
%
| 0 | nan % | 12 | 100,0 % | - |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
John P. Richard
FOU | Founder | 66 | 01/03/15 |
Founder | 64 | 10/07/15 | |
Charles Sermon
FOU | Founder | 55 | 01/03/15 |
Christine Fox
DFI | Director of Finance/CFO | 43 | 31/01/21 |
Michael Wyzga
CHM | Chairman | 69 | 23/04/19 |
Suba Krishnan
CTO | Chief Tech/Sci/R&D Officer | 59 | 07/12/20 |
John Lewicki
CTO | Chief Tech/Sci/R&D Officer | 72 | 01/07/20 |
Richard Francis
PRN | Corporate Officer/Principal | - | 01/08/19 |
Corporate Officer/Principal | 53 | 01/03/18 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Michael Wyzga
CHM | Chairman | 69 | 23/04/19 |
Director/Board Member | - | 10/11/22 | |
Director/Board Member | 59 | 23/04/19 | |
Founder | 64 | 10/07/15 | |
Director/Board Member | 70 | 01/07/15 | |
Pierre Jacquet
BRD | Director/Board Member | 57 | 20/09/21 |
Justin Roberts
BRD | Director/Board Member | - | 10/11/22 |
Annalisa Jenkins
BRD | Director/Board Member | 58 | 10/11/22 |
Jeremy Bender
BRD | Director/Board Member | 52 | 01/10/20 |
Daniel Shames
BRD | Director/Board Member | - | 10/11/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 643 204 794 | 301 926 833 ( 46,94 %) | 0 | 46,94 % |
Coordinate società
Mereo BioPharma Group Plc
1 Cavendish Place 4th Floor
W1G 0QF, London
+44 33 3023 7300
http://www.mereobiopharma.comSettore
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+18,61% | 384 Mln | |
-2,31% | 103 Mrd | |
+0,56% | 95,28 Mrd | |
+1,69% | 22,15 Mrd | |
-17,37% | 21,02 Mrd | |
-9,30% | 18,15 Mrd | |
-41,01% | 16,73 Mrd | |
-14,85% | 16,05 Mrd | |
+3,21% | 13,68 Mrd | |
+33,54% | 12,17 Mrd |
- Borsa valori
- Azioni
- Azione MREO
- Società Mereo BioPharma Group plc